Acne Drug Switch Study Raises FDA Doubts About Pregnant Women's Self-Selection
This article was originally published in The Tan Sheet
Executive Summary
The Nonprescription Drugs Advisory Committee meets on April 15 to discuss Galderma's first-in-class switch proposal for adapalene gel 0.1% indicated for treatment of acne in consumers ages 12 and older, the traditional indication for OTC acne treatments.